Top Markets
Coin of the day
Hugel, Inc. Hugel, Inc.

Hugel, Inc.

145020
Hisse Senetlerindeki Sıralama #6786
Hugel, Inc. is a biopharmaceutical firm headquartered in Chuncheon-si, South... Hugel, Inc. is a biopharmaceutical firm headquartered in Chuncheon-si, South Korea, with a presence both domestically and internationally. The company specializes in the development and manufacturing of diverse medical solutions. A primary product is its Botulinum Toxin, presented as a clear glass vial containing a white, injectable dry powder. This therapeutic is prescribed for several conditions: treating essential eyelid spasms in adults over 18; ameliorating severe frown lines linked to corrugator and/or procerus muscle activity in adults aged 18 to 65; managing upper limb spasticity following a stroke; and correcting dynamic equinus foot deformity in children with cerebral palsy aged over 2. Furthermore, it aids in improving the lateral canthal lines (crow's feet) caused by orbicularis oculi muscle activity in adults between 19 and 65. This product is marketed under various labels, including Botulax, Regenox, Zentox, Reage, Magnion, Hugel Toxin, Juvenlife, Botulim, and Botoshot. Hugel also provides hyaluronic acid dermal fillers, known as Dermalax and The Chaeum; cosmetic products under the Wellage brand; and medical devices distributed as BlueRose. Hugel, Inc. commenced operations in 2001.
Hisse Fiyatı
$173.56
Piyasa Değeri
$1.88B
Değişim (1 gün)
2.24%
Değişim (1 yıl)
-24.15%
Ülke
KR
Ticaret Hugel, Inc. (145020)

Kategori

Hugel, Inc. (145020) için P/S oranı
2026 itibarıyla P/S oranı TTM: 0
Hugel, Inc. şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 0'dir. 2026 yılının sonunda şirketin P/S oranı 0 idi.
Hugel, Inc. için P/S oranı geçmişi 2026 - 2026 arası
Her yılın sonunda P/S oranı
Yıl P/S Oranı Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için P/S oranı
Şirket P/S Oranı P/S Oranı Farkı Ülke
10.17 -
US
10.13 -
NL
2.95 -
AU
11.28 -
US
- -
CH